logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Christina W. Yde

Rigshospitalet
H指数:25
被引数:1,726

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Scalable clinical proteomics from DNA/RNA extraction flowthroughs enables integrated proteogenomic profiling from a single cancer biopsy

从DNA/RNA提取滤液中实现可扩展的临床蛋白质组学，可从单个癌症活检中实现整合的蛋白质基因组学分析

Clinical Proteomics
IF3.3
2026-09-200
OAAI
Filip Mundt; Annelaura Bach Nielsen; Juanjuan Wang; Josephine Kerzel Duel; Christina Westmose Yde; Martina Amnitzbøll Eriksen; Ulrik Lassen; Finn Cilius Nielsen; Kristoffer Rohrberg; Matthias Mann
Immune Cell Modulation of Patient-Matched Organoid Drug Response in Precision Cancer Medicine Platform

精准癌症医学平台中患者匹配类器官药物反应的免疫细胞调节

Cells
IF5.2
2026-01-300
OAAI
Silje Kjølle; Mario Presti; Jéssica de Pina Roque; Lina Hua Bisgaard; Darío Beceiro Ramos; Kamilla Westarp Zornhagen; Christina Westmose Yde; Ane Yde Schmidt; Perrine Verdys; Martin Højgaard; Ulrik Lassen; Inge Marie Svane; Kristoffer Staal Rohrberg; Marco Donia; Janine T. Erler
Copenhagen Prospective Personalized Oncology (CoPPO)—impact of comprehensive genomic profiling in more than 2000 patients in a phase I setting

哥本哈根前瞻性个性化肿瘤学（CoPPO）——在I期研究中对超过2000例患者进行综合基因组分析的影响

Annals of Oncology
IF65.4
2025-04-150
PRE
L. Belcaid; M. Højgaard; I. Tuxen; I. Spanggaard; U. Lassen; L. Robinson; M. Rossing; F. Bagger; L.B. Ahlborn; A.Y. Schmidt; J.P. Hasselby; E. Santoni-Rugiu; F.C. Nielsen; C.W. Yde; K. Rohrberg
Identifying targetable alterations predictive of distant progression in glioblastoma patients undergoing standard therapy

Chiranth S，Fougner V，Christensen IJ，Trip AK，Christiansen T，Nørøxe DS，等。识别在标准治疗下预测胶质母细胞瘤患者远处进展的可靶向性改变。神经肿瘤学进展。(2025) 7:vdaf092。doi: 10.1093/noajnl/vdaf092。

NEURO-ONCOLOGY ADVANCES
IF4.1
2025-01-011
OA
Chiranth, Shivani; Fougner, Vincent; Christensen, Ib Jarle; Trip, Anouk Kirsten; Christiansen, Terkel; Noroxe, Dorte Schou; Yde, Christina Westmose; Berthelsen, Anne Kiil; Hasselbalch, Benedikte; Lassen, Ulrik; Poulsen, Hans Skovgaard; Urup, Thomas
ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial
BMC CANCER
IF3.4
2023-02-2216
OAAI
Kringelbach, Tina; Hojgaard, Martin; Rohrberg, Kristoffer; Spanggaard, Iben; Laursen, Britt Elmedal; Ladekarl, Morten; Haslund, Charlotte Aaquist; Harslof, Laurine; Belcaid, Laila; Gehl, Julie; Sondergaard, Lise; Eefsen, Rikke Lovendahl; Hansen, Karin Holmskov; Kodahl, Annette Raskov; Jensen, Lars Henrik; Holt, Marianne Ingerslev; Oellegaard, Trine Heide; Yde, Christina Westmose; Ahlborn, Lise Barlebo; Lassen, Ulrik
A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study

在BRAF V600E突变的转移性结直肠癌患者中，每日一次的恩可非尼联合两周一次的西妥昔单抗的II期研究: 新的BEACON研究

BMC CANCER
IF3.4
2022-12-165
OAAI
Eriksen, Martina; Pfeiffer, Per; Rohrberg, Kristoffer Staal; Yde, Christina Westmose; Petersen, Lone Norgard; Poulsen, Laurids Ostergaard; Qvortrup, Camilla
Survival and T-cell tumor reactivity in patients treated with nivolumab and bevacizumab for recurrent glioblastoma in the clinical trial CA209-9UP

nivolumab和bevacizumab治疗复发性胶质母细胞瘤患者的生存率和T细胞肿瘤反应性的临床试验CA209-9UP

NEURO-ONCOLOGY
IF13.4
2022-09-050
OA
Maarup, S.; Skadborg, S.; Draghi, A.; Borch, A.; Hasselbalch, B.; Yde, C.; Svane, I; Hadrup, S.; Christensen, I; Law, I; Skjoeth-Rasmussen, J.; Scheie, D.; Skovgaard Poulsen, H.; Lassen, U.
Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study

替莫唑胺治疗前后27对胶质母细胞瘤样本的肿瘤突变负荷和纯度调整: 一项前瞻性研究

MOLECULAR ONCOLOGY
IF4.5
2021-06-254
OAAI
Schou Noroxe, Dorte; Flynn, Aidan; Westmose Yde, Christina; ostrup, Olga; Cilius Nielsen, Finn; Skjoth-Rasmussen, Jane; Brennum, Jannick; Hamerlik, Petra; Weischenfeldt, Joachim; Skovgaard Poulsen, Hans; Lassen, Ulrik
Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility - a prospective, translational study

新诊断的胶质母细胞瘤患者的基因组分析及其临床应用潜力-一项前瞻性转化研究

MOLECULAR ONCOLOGY
IF4.5
2020-09-1814
OAAI
Noroxe, Dorte S.; Yde, Christina W.; Ostrup, Olga; Michaelsen, Signe R.; Schmidt, Ane Y.; Kinalis, Savvas; Torp, Mathias H.; Skjoth-Rasmussen, Jane; Brennum, Jannick; Hamerlik, Petra; Poulsen, Hans S.; Nielsen, Finn C.; Lassen, Ulrik

研究方向

暂未获取到该数据
U
Ulrik Lassen
H 指数:53论文数:558被引数:1.4万
F
Finn Cilius Nielsen
H 指数:72论文数:439被引数:1.9万
H
Hans Skovgaard Poulsen
H 指数:50论文数:365被引数:9,060
A
Anne E. Lykkesfeldt
H 指数:42论文数:195被引数:4,273
K
Kristoffer Staal Rohrberg
H 指数:19论文数:208被引数:2,392
M
Morten Mau‐Sørensen
H 指数:38论文数:260被引数:5,476
D
Dorte Schou Nørøxe
H 指数:8论文数:49被引数:355
L
Laïla Belcaid
H 指数:9论文数:45被引数:309
L
Lise Barlebo Ahlborn
H 指数:14论文数:82被引数:1,545
A
Anne‐Vibeke Lænkholm
H 指数:43论文数:231被引数:6,966